Cidara Therapeutics, Inc. (CDTX)
Data as of , from SEC Form 4 filings.
See up to 3 months of CDTX. The 7-day demo opens the 1M and 3M ranges and puts CDTX on your watchlist.
Start 7-day demoLatest CDTX insider trades
About Cidara Therapeutics, Inc. (CDTX)
Cidara Therapeutics, Inc. files with the SEC under CIK 0001610618 and is classified as biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
CDTX Form 4 activity by transaction type, last 90 days
No Form 4 activity for CDTX in the last 90 days.
CDTX insider transactions (Form 4)
2014 Form 4 filings on record, the earliest from Oct 2, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Option exercise | Common Stock | 1,286,786 | $0.00 | $129 | |
| RA CAPITAL MANAGEMENT, L.P. | Derivative | Common Stock | 4,652,309 | $221.50 | $1.03B | |
| RA CAPITAL MANAGEMENT, L.P. | Derivative | Stock Option (right to buy) | 22,200 | - footnote F7 | - | |
| RA CAPITAL MANAGEMENT, L.P. | Derivative | Stock Option (right to buy) | 5,079 | - footnote F7 | - | |
| RA CAPITAL MANAGEMENT, L.P. | Option exercise | Pre-Funded Warrants (Right to Buy) | 1,286,786 | - footnote F7 | - | |
| RA CAPITAL MANAGEMENT, L.P. | Derivative | Series A Preferred Stock | 89,956 | $15,505.00 | $1.39B | |
| ||||||
| Nicole Negar Davarpanah - Officer | Open-market sale | Common Stock | 474 | $62.86 | $30K | |
| Daniel D. Burgess - Director | Grant or award | Stock Option (right to buy) | 11,100 | $0.00 | - | |
| Bonnie L. Bassler - Director | Grant or award | Stock Option (right to buy) | 16,000 | $0.00 | - | |
| Carin Canale-Theakston - Director | Grant or award | Stock Option (right to buy) | 16,000 | $0.00 | - | |
| Chrysa Mineo - Director | Grant or award | Stock Option (right to buy) | 19,000 | $0.00 | - | |
| Theodore R. Schroeder - Director | Grant or award | Stock Option (right to buy) | 20,500 | $0.00 | - | |
| Daniel D. Burgess - Director | Grant or award | Stock Option (right to buy) | 20,500 | $0.00 | - | |
| RA CAPITAL MANAGEMENT, L.P. | Grant or award | Common Stock | 389,716 | $14.91 | $5.81M | |
| RA CAPITAL MANAGEMENT, L.P. | Grant or award | Pre-Funded Warrants (Right to Buy) | 1,286,786 | $14.91 | $19.19M | |
| Taylor Sandison - Officer | Grant or award | Employee Stock Option (right to buy) | 166,836 | $0.00 | - | |
| Leslie Tari - Officer | Grant or award | Employee Stock Option (right to buy) | 150,224 | $0.00 | - | |
| Preetam Shah - Officer | Grant or award | Employee Stock Option (right to buy) | 130,087 | $0.00 | - | |
| Shane Ward - Officer | Grant or award | Employee Stock Option (right to buy) | 135,540 | $0.00 | - | |
| Jeffrey Stein - Officer | Grant or award | Employee Stock Option (right to buy) | 560,888 | $0.00 | - | |
CDTX insider trading FAQ
What is the latest insider trade for CDTX?
Cidara Therapeutics, Inc. (CDTX) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-01-09. The full record for CDTX runs to 14 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CDTX stock?
No insider purchases of CDTX were filed in the last 90 days.
How many insiders are selling CDTX stock?
No insider sales of CDTX were filed in the last 90 days. 1 sale is on record for this company.
Where can I see CDTX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CDTX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - RA CAPITAL MANAGEMENT, L.P. view on EDGAR
- - Nicole Negar Davarpanah view on EDGAR
- - Daniel D. Burgess view on EDGAR
- - Bonnie L. Bassler view on EDGAR
- - Carin Canale-Theakston view on EDGAR
- - Chrysa Mineo view on EDGAR
- - Theodore R. Schroeder view on EDGAR
- - Daniel D. Burgess view on EDGAR
- - RA CAPITAL MANAGEMENT, L.P.
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where CDTX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CDTX with a 7-day demo
- CDTX on your watchlist
- Every CDTX Form 4 filing on record
- Up to 3 months of CDTX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
